Valuation: Quest Laboratories Limited

Market Cap 1.71B 17.92M 15.68M 14.46M 13.38M 25.39M 25.82M 173M 67.88M 840M 67.29M 65.83M 2.91B P/E 2024 *
-
P/E 2025 12.4x
Enterprise Value 1.52B 15.92M 13.93M 12.85M 11.89M 22.56M 22.94M 154M 60.31M 746M 59.78M 58.49M 2.59B EV / Sales 2024 *
-
EV / Sales 2025 1.43x
Free-Float
99%
Yield 2024 *
-
Yield 2025 -
1 day+1.42%
1 week-5.07%
Current month-9.28%
1 month-10.10%
3 months-16.82%
6 months-12.32%
Current year-19.16%
1 week 87
Extreme 87
95.05
1 month 87
Extreme 87
122
Current year 87
Extreme 87
152.6
1 year 84
Extreme 84
152.6
3 years 75.15
Extreme 75.15
196.8
5 years 75.15
Extreme 75.15
196.8
10 years 75.15
Extreme 75.15
196.8
Manager TitleAgeSince
Chief Executive Officer 59 2023-12-31
Director of Finance/CFO 38 2023-12-31
Compliance Officer - 2025-09-02
Director TitleAgeSince
Chairman 59 2023-12-31
Director/Board Member 30 2021-03-04
Director/Board Member 72 2024-01-09
Change 5-day change 1-year change 3-year change Capi.($)
+1.42%-5.07%-1.93% - 15.02M
+0.09%+0.25%+54.65%+169.19% 1,084B
-1.63%-1.50%+65.79%+62.70% 634B
-1.12%-4.27%+31.10%+84.44% 447B
+0.18%-1.76%+29.04%+26.51% 330B
-6.22%-8.14%+28.87%+32.09% 295B
-1.27%-2.91%+27.42%+46.39% 285B
-0.93%-3.57%-27.74%-40.38% 218B
-1.19%-2.81%+22.63%+66.30% 199B
-0.72%+2.72%+19.07%+81.19% 169B
Average -1.01%-2.02%+24.89%+58.71% 365.99B
Weighted average by Cap. -0.90%-1.18%+38.91%+84.80%

Financials

2024 2025
Net sales 826M 8.65M 7.57M 6.98M 6.46M 12.25M 12.46M 83.56M 32.76M 405M 32.47M 31.77M 1.4B 1.04B 10.89M 9.53M 8.79M 8.13M 15.43M 15.69M 105M 41.25M 511M 40.89M 40.01M 1.77B
Net income 101M 1.06M 925K 853K 789K 1.5M 1.52M 10.22M 4M 49.57M 3.97M 3.88M 172M 136M 1.42M 1.24M 1.15M 1.06M 2.01M 2.05M 13.73M 5.38M 66.62M 5.34M 5.22M 231M
Net Debt 49.37M 517K 452K 417K 386K 733K 745K 5M 1.96M 24.25M 1.94M 1.9M 83.98M -191M -2M -1.75M -1.61M -1.49M -2.83M -2.88M -19.31M -7.57M -93.7M -7.5M -7.34M -325M
Logo Quest Laboratories Limited
Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces a variety of products, comprising ethical drugs, generic drugs, and over-the-counter drugs (OTC). These products are available in various forms, such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids. The tablets include Cetirizine Hydrochloride Tablet IP 10 mg, Zinc Sulphate Dispersible Tablet IP, Diclofenac Sodium Tablet BP, and others. It offers dry syrup and suspension, such as Ferrous Sulphate & Folic Acid Syrup, Albendazole Suspension IP, Zinc Oral Solution USP, Alpha Amilase & Pepsine, Sucralfate Suspension, and others. Its ointments include Silver Sulphadiazine Cream IP, Diclofenac Diethylamino IP Gel, and Povidone Iodine Ointment USP.
Employees
50
Date Price Change Volume
26-07-09 ₹89.00 +1.42% 2,400
26-07-08 ₹87.75 -0.28% 18,000
26-07-07 ₹88.00 -3.08% 19,200
26-07-06 ₹90.80 -4.37% 69,600
26-07-03 ₹94.95 +1.28% 50,400
  1. Stock Market
  2. Stocks
  3. QUESTLAB Stock